Chemoinformaics analysis of Lambertine hydroxide
| Molecular Weight | 355.39 | nRot | 2 |
| Heavy Atom Molecular Weight | 334.222 | nRig | 25 |
| Exact Molecular Weight | 355.142 | nRing | 5 |
| Solubility: LogS | -4.675 | nHRing | 3 |
| Solubility: LogP | 3.133 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 52.5127 |
| nHD | 0 | BPOL | 28.8533 |
| QED | 0.789 |
| Synth | 3.152 |
| Natural Product Likeliness | 0.913 |
| NR-PPAR-gamma | 0.043 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.062 |
| Pgp-sub | 0.975 |
| HIA | 0.002 |
| CACO-2 | -5.38 |
| MDCK | 0.0000335 |
| BBB | 0.907 |
| PPB | 0.95243 |
| VDSS | 0.996 |
| FU | 0.0359728 |
| CYP1A2-inh | 0.635 |
| CYP1A2-sub | 0.741 |
| CYP2c19-inh | 0.277 |
| CYP2c19-sub | 0.83 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.492 |
| CYP2d6-inh | 0.86 |
| CYP2d6-sub | 0.881 |
| CYP3a4-inh | 0.87 |
| CYP3a4-sub | 0.532 |
| CL | 13.685 |
| T12 | 0.415 |
| hERG | 0.063 |
| Ames | 0.151 |
| ROA | 0.084 |
| SkinSen | 0.231 |
| Carcinogencity | 0.884 |
| EI | 0.011 |
| Respiratory | 0.165 |
| NR-Aromatase | 0.237 |
| Antiviral | Yes |
| Prediction | 0.771851 |